Commercialization of integrated continuous and single-use BIO-production capture platform (ICS)

Ended Project Grant Awarded Last action

Award ID
R44GM117682
Recipient
Awarding agency
Obligated
$8,941,714

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date
Originally
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $503,755
Amendment $503,755
Amendment $707,318
Amendment $707,318
Amendment $707,318
Amendment $1,284,233
Amendment $1,284,233
Amendment $1,284,233
Amendment $0
Amendment Continuation application for the development of integrated continuous and single-use (ICS) bioproduction platform (phase IIB) $0
Amendment $0
Amendment $0
Amendment $255,778
Amendment $540,290
Amendment $941,104
Amendment $0
Original award $222,379
Show all 19

Quick answers

Who received award R44GM117682?

R44GM117682 was awarded to Chromatan Inc. by National Institute of General Medical Sciences (National Institutes of Health) on January 1, 2016.

How much is award R44GM117682 worth?

$8,941,714 has been obligated on R44GM117682.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award